Barrington Research Maintains Outperform on OPKO Health, Lowers Price Target to $1.5
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:OPK) with a Outperform and lowers the price target from $2.25 to $1.5.
Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:OPK) with a Outperform and lowers the price target from $2.25 to $1.5.